Clinical Trials
26
Active:0
Completed:4
Trial Phases
5 Phases
Phase 1:7
Phase 2:11
Phase 3:4
+2 more phases
Drug Approvals
4
FDA:4
Drug Approvals
Clinical Trials
Distribution across different clinical trial phases (26 trials with phase data)• Click on a phase to view related trials
Phase 2
11 (42.3%)Phase 1
7 (26.9%)Phase 3
4 (15.4%)Not Applicable
2 (7.7%)Phase 4
2 (7.7%)Phase III Clinical Study on the Efficacy and Safety of Semaglutide and Ozempic® in Patients With Type 2 Diabetes
Not Applicable
Not yet recruiting
- Conditions
- Type 2 Diabetes (T2DM)
- Interventions
- Drug: F027
- First Posted Date
- 2025-07-01
- Last Posted Date
- 2025-07-01
- Lead Sponsor
- Shandong New Time Pharmaceutical Co., LTD
- Target Recruit Count
- 496
- Registration Number
- NCT07046273
A Phase III Clinical Study of Valsartan Oral Solution for the Treatment of Hypertension in Children and Adolescents
Phase 3
- Conditions
- Essential Hypertension
- Interventions
- Drug: Valsartan Oral SolutionDrug: Placebo
- First Posted Date
- 2025-03-07
- Last Posted Date
- 2025-03-07
- Lead Sponsor
- Shandong New Time Pharmaceutical Co., LTD
- Target Recruit Count
- 342
- Registration Number
- NCT06863987
- Locations
- 🇨🇳
Shandong New Time Pharmaceutical Co.LTD,, Linyi, Shandong, China
Phase III Clinical Study of Cetirizine Hydrochloride Injection in Treatment of Acute Urticaria
Phase 3
Recruiting
- Conditions
- Acute Urticaria
- Interventions
- Drug: Cetirizine Hydrochloride InjectionDrug: Diphenhydramine Hydrochloride Injection
- First Posted Date
- 2025-02-11
- Last Posted Date
- 2025-02-11
- Lead Sponsor
- Shandong New Time Pharmaceutical Co., LTD
- Target Recruit Count
- 284
- Registration Number
- NCT06819774
- Locations
- 🇨🇳
Chinese Academy of Medical Sciences, Peking Union Medical College Hospital, BeiJing, Beijing, China
Phase II Clinical Study of Vonorasan Fumarate Injection in the Treatment of Peptic Ulcer Bleeding
Phase 2
Not yet recruiting
- Conditions
- Peptic Ulcer Bleeding
- Interventions
- Drug: Vonorasan fumarate injection1Drug: Vonorasan fumarate injection2
- First Posted Date
- 2025-01-20
- Last Posted Date
- 2025-01-20
- Lead Sponsor
- Shandong New Time Pharmaceutical Co., LTD
- Target Recruit Count
- 150
- Registration Number
- NCT06783257
A Phase Ⅱ Study of Mosapride Citrate Injection in the Treatment of Postoperative Gastrointestinal Dysfunction
Phase 2
Recruiting
- Conditions
- Postoperative Gastrointestinal Dysfunction
- Interventions
- Drug: Mosapride Citrate Injection(low)Drug: Mosapride Citrate Injection(high)Drug: Placebo
- First Posted Date
- 2025-01-20
- Last Posted Date
- 2025-01-20
- Lead Sponsor
- Shandong New Time Pharmaceutical Co., LTD
- Target Recruit Count
- 150
- Registration Number
- NCT06782594
- Locations
- 🇨🇳
Shandong New Time Pharmaceutical Co., LTD, Feixian, Shandong, China
🇨🇳Tongji Hospital Affiliated to Tongji Medical College Hust, Wuhan, China
- Prev
- 1
- 2
- 3
- 4
- 5
- 6
- Next
News
No news found